XT-150: Clinical Trials

8 trials of XT-150, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 not yet recruiting, 1 terminated, 1 withdrawn. 6 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 3, Not yet recruiting 1, Terminated 1, Withdrawn 1
Phase 23Completed 2, Withdrawn 1

Follow XT-150: new trials by email Literature Review of XT-150 trials Research Report on XT-150

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety Study of XT-150 in Participants With ALS
XT-150 - Amyotrophic Lateral Sclerosis (ALS)
Phase 1Not yet recruitingXalud Therapeutics, Inc.82027-03-012026-07-29
Safety and Efficacy of XT-150 for Facet Joint Osteoarthritis Pain
XT-150, Placebo - Facet Joint Pain, Back Pain
Phase 2CompletedXalud Therapeutics, Inc.752022-02-242025-01-15
Preliminary Safety and Efficacy of XT-150 in Facet Joint Osteoarthritis
XT-150 - Osteoarthritis, Spine
Phase 1 / Phase 2WithdrawnXalud Therapeutics, Inc.2021-10-012022-03-17
Safety and Efficacy of XT-150 for Treatment of Neuropathic Pain
XT-150, Placebo - Neuropathic Pain
Phase 1TerminatedXalud Therapeutics, Inc.52021-04-142023-01-23
Efficacy and Safety of XT-150 in Osteoarthritis of the Knee
XT-150, Placebo - Osteoarthritis, Knee
Phase 2CompletedXalud Therapeutics, Inc.2892020-02-142025-03-27
Follow on Extension of XT-150-1-0201
XT-150 - Osteoarthritis, Knee
Phase 1CompletedXalud Therapeutics, Inc.162019-03-202020-01-18
Safety, Tolerability, and Efficacy of XT-150 for the Treatment of Osteoarthritic Pain
XT-150 - Osteoarthritis, Knee
Phase 1CompletedXalud Therapeutics, Inc.322018-06-082019-11-08
Preliminary Evaluation of Safety, Tolerability, and Efficacy of XT-150 for the Treatment of Osteoarthritic Pain
XT-150 - Osteoarthritis, Knee
Phase 1CompletedXalud Therapeutics, Inc.242018-03-212019-07-05

Conditions studied

Inflammation (5)  ·  Osteoarthritis, Knee (4)  ·  Pain (3)  ·  Amyotrophic Lateral Sclerosis (1)  ·  Back Pain (1)  ·  Neuralgia (1)  ·  Osteoarthritis (1)  ·  Osteoarthritis, Spine (1)

Sponsors

Xalud Therapeutics, Inc. (8)

Countries

Australia (5)  ·  United States (4)

Top investigators

Mark Rickman, MD (2)  ·  Howard Rutman, MD (1)  ·  Howard Rutman, MD,MBA (1)  ·  Morgan Stokes (1)  ·  Stephen Collins, MD, PhD (1)

Results publications

PMID 40826764, PMID 41090674